Back to KNSA
VANGUARD GROUP INC KNSA Position History
Kiniksa Pharmaceuticals International, plc
Quarters held
15
Latest value
$1.3M
Q4 2025
Peak value
$125.8M
First seen
Q1 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2025 | $73.1M |
| Q1 2025 | $520K |
| Q1 2025 | $211K |
| Q1 2025 | $812K |
| Q2 2025 | $85.8M |
| Q2 2025 | $648K |
| Q2 2025 | $212K |
| Q3 2025 | $116.7M |
| Q3 2025 | $910K |
| Q3 2025 | $298K |
| Q3 2025 | $1.1M |
| Q4 2025 | $125.8M |
| Q4 2025 | $966K |
| Q4 2025 | $317K |
| Q4 2025 | $1.3M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q4 2025 | $1.3M | 32.1K | — | — |
| Q4 2025 | $317K | 7.7K | — | — |
| Q4 2025 | $966K | 23.4K | — | — |
| Q4 2025 | $125.8M | 3.05M | — | — |
| Q3 2025 | $1.1M | 27.1K | — | — |
| Q3 2025 | $298K | 7.7K | — | — |
| Q3 2025 | $910K | 23.4K | — | — |
| Q3 2025 | $116.7M | 3.00M | — | — |
| Q2 2025 | $212K | 7.7K | — | — |
| Q2 2025 | $648K | 23.4K | — | — |
| Q2 2025 | $85.8M | 3.10M | — | — |
| Q1 2025 | $812K | 36.6K | — | — |
| Q1 2025 | $211K | 9.5K | — | — |
| Q1 2025 | $520K | 23.4K | — | — |
| Q1 2025 | $73.1M | 3.29M | — | — |